1-5 of 5
Ronald Herbst
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment

Susannah L. Hewitt, Dyane Bailey, John Zielinski, Ameya Apte, Faith Musenge, Russell Karp, Shannon Burke, Fabien Garcon, Ankita Mishra, Sushma Gurumurthy, Amanda Watkins, Kristen Arnold, James Moynihan, Eleanor Clancy-Thompson, Kathy Mulgrew, Grace Adjei, Katharina Deschler, Darren Potz, Gordon Moody, David A. Leinster, Steve Novick, Michal Sulikowski, Chris Bagnall, Philip Martin, Jean-Martin Lapointe, Han Si, Chris Morehouse, Maja Sedic, Robert W. Wilkinson, Ronald Herbst, Joshua P. Frederick, Nadia Luheshi
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (23): 6284–6298.
https://doi.org/10.1158/1078-0432.CCR-20-0472
Published: 01 December 2020
View article titled, Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment
Open the PDF for Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment in another window
Includes: Supplementary data
Journal Articles

The Immunoscore: Colon Cancer and Beyond

Helen K. Angell, Daniela Bruni, J. Carl Barrett, Ronald Herbst, Jérôme Galon
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (2): 332–339.
https://doi.org/10.1158/1078-0432.CCR-18-1851
Published: 15 January 2020
View article titled, The Immunoscore: Colon Cancer and Beyond
Open the PDF for The Immunoscore: Colon Cancer and Beyond in another window
Journal Articles

SLC46A3 as a Potential Predictive Biomarker for Antibody–Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads

Krista Kinneer, John Meekin, Arnaud C. Tiberghien, Yu-Tzu Tai, Sandrina Phipps, Christine Mione Kiefer, Marlon C. Rebelatto, Nazzareno Dimasi, Alyssa Moriarty, Kyriakos P. Papadopoulos, Sriram Sridhar, Stephen J. Gregson, Michael J. Wick, Luke Masterson, Kenneth C. Anderson, Ronald Herbst, Philip W. Howard, David A. Tice
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (24): 6570–6582.
https://doi.org/10.1158/1078-0432.CCR-18-1300
Published: 13 December 2018
View article titled, SLC46A3 as a Potential Predictive Biomarker for Antibody–Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads
Open the PDF for SLC46A3 as a Potential Predictive Biomarker for Antibody–Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads in another window
Includes: Supplementary data
Journal Articles

TP53, STK11, and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma

Jérôme Biton, Audrey Mansuet-Lupo, Nicolas Pécuchet, Marco Alifano, Hanane Ouakrim, Jennifer Arrondeau, Pascaline Boudou-Rouquette, François Goldwasser, Karen Leroy, Jeremy Goc, Marie Wislez, Claire Germain, Pierre Laurent-Puig, Marie-Caroline Dieu-Nosjean, Isabelle Cremer, Ronald Herbst, Hélène Blons, Diane Damotte
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (22): 5710–5723.
https://doi.org/10.1158/1078-0432.CCR-18-0163
Published: 15 November 2018
View article titled, <em>TP53, STK11</em>, and <em>EGFR</em> Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma
Open the PDF for <em>TP53, STK11</em>, and <em>EGFR</em> Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

CAT-8015: A Second-Generation Pseudomonas Exotoxin A–Based Immunotherapy Targeting CD22-Expressing Hematologic Malignancies

Ralph F. Alderson, Robert J. Kreitman, Tianling Chen, Peter Yeung, Ronald Herbst, Judy A. Fox, Ira Pastan
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (3): 832–839.
https://doi.org/10.1158/1078-0432.CCR-08-1456
Published: 02 February 2009
View article titled, CAT-8015: A Second-Generation <em>Pseudomonas</em> Exotoxin A–Based Immunotherapy Targeting CD22-Expressing Hematologic Malignancies
Open the PDF for CAT-8015: A Second-Generation <em>Pseudomonas</em> Exotoxin A–Based Immunotherapy Targeting CD22-Expressing Hematologic Malignancies in another window